Provided by Tiger Fintech (Singapore) Pte. Ltd.

Nice Ltd

164.42
+0.65000.40%
Post-market: 164.420.00000.00%17:07 EDT
Volume:267.29K
Turnover:43.89M
Market Cap:10.40B
PE:24.32
High:165.29
Open:164.00
Low:163.54
Close:163.77
Loading ...

Stock Track | NICE Ltd Plunges 14.63% Premarket on Disappointing Q1 Earnings Guidance

Stock Track
·
20 Feb

NICE Q4 Adjusted Earnings Rise, Revenue Declines

MT Newswires Live
·
20 Feb

Nice: Q4 Earnings Snapshot

Associated Press Finance
·
20 Feb

Stock Track | NICE Ltd Plunges 7.56% Pre-Market as Q1 Earnings Guidance Falls Short of Estimates

Stock Track
·
20 Feb

GUIDANCE: (NICE) NICE Expects Q1 Adjusted EPS Range $2.78 - $2.88, vs. FactSet Est of $2.98

MT Newswires Live
·
20 Feb

NICE Q4 2024 Adj EPS $3.02 Beats $2.98 Estimate, Sales $721.60M Beat $720.26M Estimate

Benzinga
·
20 Feb

NICE Is Maintained at Buy by Citigroup

Dow Jones
·
19 Feb

Northland Securities Sticks to Their Buy Rating for NICE (NICE)

TIPRANKS
·
18 Feb

Nice Ltd expected to post earnings of $2.95 a share - Earnings Preview

Reuters
·
18 Feb

NICE Ltd. (NICE): Among the Cheap Technology Stocks to Buy According to Analysts

Insider Monkey
·
15 Feb

Outlook Therapeutics® Reports Financial Results for First Quarter Fiscal Year 2025 and Provides Corporate Update

GlobeNewswire
·
14 Feb

Press Release: NICE Provides Webcast and Dial-in Details for its Fourth Quarter 2024 Results Teleconference

Dow Jones
·
13 Feb

Vertiv Holdings Co: A Key Exit in Barrow, Hanley, Mewhinney & Strauss's Latest 13F Filing

GuruFocus.com
·
13 Feb

NICE and FDNY Collaborate to Enhance Digital Evidence Management

TIPRANKS
·
10 Feb

NICE Selected by Fire Department of New York to Digitally Transform Evidence Management

Business Wire
·
10 Feb

NICE Ltd. (NICE): Expanding AI-Driven Solutions with Strong Financial Results

Insider Monkey
·
03 Feb

NICE Ltd. (NICE): A Bull Case Theory

Insider Monkey
·
01 Feb

Vertex Announces CASGEVY® Reimbursement Agreement for the Treatment of Sickle Cell Disease in England

Business Wire
·
31 Jan

ALK’s house dust mite tablet (ACARIZAX®) now recommended by NICE for use in the UK health system

GlobeNewswire
·
30 Jan

Is NICE Ltd. (NICE) the Cheap AI Stock to Buy in 2025?

Insider Monkey
·
29 Jan